Induction of cMrp/cMoat gene expression by cisplatin, 2- acetylaminofluorene, or cycloheximide in rat hepatocytes

Hepatology

Volumn 26, Issue 4, 1997, Pages 980-985

  Kauffmann, Hans Martin ^a   Keppler, Dietrich ^b   Kartenbeck, Jürgen ^b   Schrenk, Dieter ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c University of Koblenz Landau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CISPLATIN; CYCLOHEXIMIDE; MESSENGER RNA; N (2 FLUORENYL)ACETAMIDE; PROTEIN SYNTHESIS INHIBITOR;

ADOLESCENT; ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

EID: 0030817669     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1997.v26.pm0009328323     Document Type: Article

References (30)

1. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-1654.
2. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kD membrane bound glycoprotein. Cancer Res 1993;53:3658-3661.
3. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SPC, Deeley RG. Characterization of the Mr 190.000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 1995; 55:102-110.
4. Ma L, Krishnamachary N, Center MS. Phosphorylation of the multidrug resistance-associated protein gene encoded protein P190. Biochemistry 1995;34:3338-3343.
5. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994;54:4833-4836.
6. 4 and structurally related conjugates. J Biol Chem 1994;269:27807-27810.
7. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, de Vries EGE, et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci U S A 1994;91:13033-13037.
8. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996;56:988-994.
9. Flens MJ, Zaman GJR, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, van der Groep P, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996;148:1237-1247.
10. Nooter K, Westerman AM, Flens MJ, Zaman GJR, Scheper RJ, van Wingerden KE, Burger H, et al. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995; 1:1301-1310.
11. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54:357-361.
12. Mayer R, Kartenbeck J, Büchler M, Jedlitschky G, Leier I, Keppler D. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol 1995;131:137-150.
13. Paulusma CC, Bosma PJ, Zaman GJR, Bakker CTM, Otter M, Scheffer GL, Scheper RJ, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996;271:1126-1128.
14. Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-15098.
15. Huber M, Guhlmann A, Jansen PLM, Keppler D. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. HEPATOLOGY 1987;7:224-228.
16. Gant TW, Silverman JA, Bisgaard HC, Burt RK, Marino PA, Thorgeirsson SS. Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450 IA gene family expression in primary hepatocyte cultures and rat liver. Mol Carcinog 1991;4:499-509.
17. Burt RK, Thorgeirsson SS. Coinduction of MDR-1 multidrug resistance and cytochrome P-450 genes in rat liver by xenobiotics. J Natl Cancer Inst 1988;80:1383-1386.
18. Gant TW, Silverman JA, Thorgeirsson SS. Regulation of P-glycoprotein gene expression in hepatocyte cultures and liver cell lines by a transacting transcriptional repressor. Nucleic Acids Res 1992;20:2841-2846.
19. Schrenk D, Gant TW, Michalke A, Orzechowski A, Silverman JA, Battula N, Thorgeirsson SS. Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis 1994;15:2541-2546.
20. Fort P, Marty L, Piechaezyl M, Sabrouty SE, Dani C, Jeanteur P, Blanchard JM. Various rat tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985;13:1431-1443.
21. Becker A, Neumeier R, Heidrich C, Loch N, Hartel S, Reutter W. Cell surface glycoproteins of hepatocytes and hepatoma cells identified by monoclonal antibodies. J Cell Biol 1986;131:137-149.
22. Lee CH, Bradley G, Zhang J-T, Ling V. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J Cell Physiol 1993;157:392-402.
23. Fardel O, Morel F, Guillouzo A. P-glycoprotein expression in human, mouse, hamster, and rat hepatocytes in primary culture. Carcinogenesis 1993;14:781-783.
24. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad MF, Avruch J, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156-160.
25. Fornace AJ Jr., Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 1989; 9:4196-4203.
26. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
27. Schuetz JD, Strom SC, Schuetz EG. Induction of P-glycoprotein mRNA by protein synthesis inhibition is not controlled by a transcriptional repressor protein in rat and human liver cells. J Cell Physiol 1995;165: 261-272.
28. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747-1750.
29. Zhu Q, Center MS. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 1994;54:4488-4492.
30. Eijdems EWHM, de Haas M, Coco-Martin JM, Ottenheim CPE, Zaman GJR, Dauwerse HG, Breuning MH, et al. Mechanisms of MRP overexpression in four human lung cancer cell lines and analysis of the human MRP amplicon. Int J Cancer 1995;60:676-684.